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Currently, experimental animals are widely used in biological and medical research.
However, the scientific community has raised several bioethical concerns, such as the
number of animals required to achieve reproducible and statistically relevant results.
These concerns involve aspects related to pain, discomfort, and unwanted animal loss.
Retrospectively, we compare two different approaches for anesthesia dosage: a mobile
app for dose calculation and a standard dose calculation. A total of 939 C57BL/6J and
Swiss mice were analyzed. We collected data on intraoperative and anesthesia-related
mortality as described in electronic or physical handwritten records. Our results showed
that the mobile app approach significantly reduces anesthetic-related deaths upon using
doses of ketamine and xylazine. The results suggest that anesthesia-related mortality
can be minimized even more using information technology approaches, helping to solve
an old but transversal challenge for researchers working with experimental mice. The
mobile app is a free and open code which could be implemented worldwide as an
essential requirement for all anesthetic procedures in mice using xylazine and ketamine
combination. As an open code app, the Labinsane initiative could also represent the
starting point to unify and validate other anesthetic procedures in different species
and strains.
Keywords: xylazine, anesthesia, mortality and morbidity, smartphone, mobile app
INTRODUCTION
Annually, millions of animals are used for experimental purposes (1–3). Experimental mice
are usually anesthetized intraperitoneally with a ketamine and xylazine solution (4–7). An
intraperitoneal procedure permits rapid application and fast anesthetic effect. However, the reasons
why mice die during the anesthetic procedure could be attributed to the inappropriate ketamine
and xylazine dosage, the lack of supplemental oxygen, and attention to details such as body
temperature, stress associated with handling, and incorrect intraperitoneal technique. Moreover,
previous intraperitoneal ketamine and xylazine combinations have caused several challenges
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related to a low margin of safety, prolonged recovery, and
persistence of lost reflexes in mice (5, 8, 9). The ketamine and
xylazine doses range from 60 to 200mg kg−1 of ketamine and
4 to 26.4mg kg−1 of xylazine (4, 5, 8–11). However, serious
inconsistent rates of anesthesia-related mortality (0–100%) have
been reported (5, 8–11).
Recent studies have shown that the MIT App Inventor, a
free and open-source software, can improve the performance
and quality of the data analyzed, helping operators to make
well-informed decisions (12). A previous report validated a
smartphone app for the calculation of CO2 in inhalational
anesthesia (13), supporting the concept that a mobile app could
help operators to calculate individual anesthetic doses. Here, our
objective was to develop a mobile app to improve the accuracy
of intraperitoneal anesthetic doses for mice. In this way, we
used a range of previously tested safe doses (5, 11), herein
ketamine (mg kg−1), and xylazine (mg kg−1), in the following
proportions: 70/7, 80/8, and 100/10, which are now contained in
the “Labinsane” mobile app. Then, we compared the Labinsane
anesthetic protocol to the protocol of 133mg kg−1 ketamine with
27mg kg−1 xylazine.
MATERIALS AND METHODS
Retrospectively, anesthetic procedure records from C57BL/6J
and Swiss mice were included. We collected electronic and
physical handwritten records written between 2015 and 2021
from eight researchers (Figure 1). The records included from
different projects were approved by the ethical committee of
the University Campinas (#4330-1A, #5521-1, #5425-1, #5349-
1, #4637-1, #4072-1, #3826-1, #5414-1, #4930-1 and #4699-1).
Records of anesthetic procedures were conducted according to
the “Guide for the Care andUse of Laboratory Animals” (14). The
mice were maintained under specific pathogen-free conditions in
individual cages in a regimen of 12-h dark and 12-h light cycles
and room temperature of 21◦C. All mice had ad libitum access to
food (3.7 kcal g−1) and water.
Criteria for Inclusion
Anesthetic records from intraoperative mortality were collected.
Anesthesia-related mortality was defined as lost breath or rigor
mortis up to 2 h after the induction of anesthesia. The anesthetic
procedure characteristics were as follows: intraperitoneal route,
using an insulin syringe, 31G needle, sterile saline solution or
distilled water for injections, 10 g/100ml stock ketamine and
2 g/100ml stock xylazine (C57BL/6J), or 10 g/100ml stock
ketamine, 2 g/100ml stock xylazine, and 0.5 g/100ml stock
diazepam (Swiss). The animals were on a chow diet, and
individual weights were measured on the same day of the
anesthetic procedures. We collected records from animals of two
procedures: two symmetrical full-thickness excisional wounds
(6-mm biopsy punch) created on the back of each mouse as
described previously (15) and stereotaxic surgery carried out
using a stereotaxic frame (16). All surgeries were conducted up
to 1 h after anesthesia induction. Immediately after surgery, the
mice were placed on a new germ-free surface in a temperature-
controlled room (25◦C), without oxygen supplementation or
monitoring of the temperature of the animal. Furthermore, only
male mice were included.
The anesthetic injections are a routine procedure in our lab.
Records with the following pattern were selected: using only
a mixture of xylazine (Anasedan, Brazil), ketamine (Dopalen,
Brazil), with or without diazepam, and saline (0.9%) solution.
Intraperitoneal injections were performed in mice in the dorsal
recumbent position. The anesthetic combination was made up as
a single injection.
Criteria for Exclusion
All incomplete records were excluded from the analysis:
anesthesia-related mortality, lost breath, or rigor mortis
occurring after 2 h after induction of anesthesia, mice fed with
a high-fat diet, or animals treated with different specific care
support before, during, or after the anesthetic procedure such as
oxygen supplementation.
Anesthetic Procedure Screened
For both the standard dose and individual dose, the animals
were weighed on the same day of the anesthetic procedure.
The anesthetic combination was freshly prepared for each
experiment, as previously described (10). The final solution was
used immediately. Standard doses were prepared as previously
described (6), with some local adaptations. Briefly, the final
solution of the standard dose was prepared with 400 µl xylazine
(2 g/100ml), 400 µl ketamine (10 g/100ml), and 200 µl saline
solution. The standard dose combination (80–100 µl of the
mixture, according to weight) was administered intraperitoneally
once by procedure. The final solution of the individual dose
was prepared and calculated by the Labinsane mobile app.
Briefly, the mobile app processes body weight, calculates a master
anesthetic combination, and then indicates the individual volume
(in µl) to administer for each individual mouse (Figure 2). A
specific individual dose adjusted to the body weight of the mouse
was administered intraperitoneally once by procedure. For the
C57BL/6 strain, a range of previously tested safe doses was used.
Herein, ketamine (mg kg−1) and xylazine (mg kg−1) were in the
following proportions: 70/7, 80/8, and 100/10 (3, 7), while for the
Swiss strain, we added diazepam (5mg kg−1) (12).
Statistical Analyses
Data extracted from the original records were pooled on a
Microsoft Excel spreadsheet (Microsoft Corporation, 2007). All
statistical tests were performed in GraphPad Prism (6.0v). Data
were analyzed with Fisher’s exact test (two-sided) and odds
ratios. Statistical significance was set as alpha <0.05 and 95%
confidence interval (CI). For the linearmodel, we used amodified
Poisson regression model, with robust variance (17). The model
was adjusted considering death as the dependent variable. The
variables “app used”, “strain,” and “age” were also considered as
independent variables. In the results, the estimates obtained from
the prevalence ratio were presented as well as their respective
confidence intervals and p-values.
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FIGURE 1 | Anesthetic records from C57BL/6J and Swiss mice Collected records from Standard or Mobile app approach of anesthesia-related mortality. Records
were collected between 2015 and 2021.
FIGURE 2 | Labinsane schematic workflow. Individual animal weights were processed by the Labinsane mobile app. A master anesthetic cocktail was calculated
based on the total number of animals and weights. The Mobile app approach showed an adjusted-to-weight anesthetic dose for each animal.
Labinsane Formula
x = A+ B+ C
y = A+ B + C + D
The x formula describes the final master anesthetic solution for
the C57BL/6 mice. The y formula describes the final master
anesthetic solution for the Swiss mice. In both formulas, A
represents the final ketamine stock volume, B the final xylazine
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“B” from the Labinsane formula is the sum of all body









“D” from the Labinsane formula is the sum of all body
weights of mice times diazepam prescription times diazepam
stock concentration.
C = (A+ B) × 4
C = (A+ B+ D) × 3
“C” from the Labinsane formula is the sum of the final ketamine
stock volume and final xylazine stock volume times the dilution
factor. The dilution factor here is a constant: “4” for C57BL/6
mice and “3” for Swiss mice.
The records collected described three different dose
prescriptions of ketamine (mg kg−1) and xylazine (mg kg−1)
in the following proportions: 70/7, 80/8, and 100/10, with the
same prescription for diazepam (5mg kg−1). The anesthetic
dose prescription was defined according to the need for long or
short procedures. For the standard protocol, we collected records
describing 133mg kg−1 ketamine and 27mg kg−1 xylazine of
dose prescription.
RESULTS
Labinsane Mobile App Decreased
Anesthesia-Related Mortality
Over the 6 years of the study, 939 anesthetized mice were
evaluated: 754 C57BL/6 and 185 Swiss mice (Table 1). This
study identified 25 intraoperative and anesthesia-related deaths
within all anesthetic procedures. The individual protocol showed
an anesthesia-related mortality rate of 1.03%. On the other
hand, mice anesthetized using the standard protocol showed
an anesthesia-related mortality rate of 10.24% (Table 2). The
association between the mobile app and survival outcome was
statistically significant (Table 2). Moreover, the mobile app
approach suggests a protective effect (Table 3), with a prevalence
ration of 0.06-fold the anesthesia-related deaths compared to the
standard dose procedure (odds ratio, 0.06; 95% CI, 0.02–0.13; p
< 0.0001). We excluded 123 electronic records of mice fed with
a high-fat diet or of animals that received different specific care
support such as oxygen supplementation.
Different doses of ketamine/xylazine for the mobile app
protocol (70/7, 80/8, and 100/10 mg/mg per kg) or standard
protocol (133/27 mg/mg per kg) were evaluated. Identified
as the higher anesthesia-related mortality dose was 133mg of
ketamine/27mg of xylazine per kilogram when compared to the
other weight-adjusted doses (Table 2).
Next, it was evaluated whether different strains, C57BL/6 or
Swiss, age, or surgical procedure could influence the anesthesia-
related mortality rate. No significant difference in anesthesia-
relatedmortality was identified between C57BL/6 and Swissmice,
7- and 8-week-old, or between full-thickness excisional biopsy
and stereotaxic surgery (Tables 2, 3).
TABLE 1 | Characteristics of mice.
Number of animals Standard Individual
Average age (weeks ± SD) Swiss (185) 8.0 (0) 8.0 (0)
C57BL/6J (754) 7.6 (0.5) 8.0 (0)
Sex (%) Females (0) 0 0
Males (939) 100 100
Strain (%) Swiss (185) 49 51
C57BL/6J (754) 16 84
Average weight (g) Swiss (185) 33.8 33.5
C57BL/6J (754) 25.2 25.1
Surgical procedure (%) Stereotaxic surgery (387) 32.2 67.8
Full-thickness biopsy (552) 17.2 82.8
Age, sex, strain, weight, and procedure profile of mice with total number, separated by
standard or individual protocol. Values expressed in weeks with standard deviation (weeks
± SD), percentage (%), and grams (g).
TABLE 2 | Multivariables.
Variable Death p-Value
No Yes
n % n %
App used <0.0001a
No 149 89.76 17 10.24
Yes 765 98.97 8 1.03
Strain 0.8014a
C57 733 97.21 21 2.79
Swiss 181 97.84 4 2.16
Concentration <0.0001a
70–100 765 98.97 8 1.03
133 149 89.76 17 10.24
Age, weeks 0.0880a
7 61 93.85 4 6.15
8 853 97.60 21 2.40
Procedure 0.5840b
Full-thickness excisional biopsy 535 97.10 16 2.90
Stereotaxic surgery 379 97.68 9 2.32




Labinsane Mobile App Matched All
Anesthetic Dose Calculations
To validate the mobile app anesthetic dose calculation, the
Labinsane app was challenged to reproduce the results of the
individual doses calculated by a Microsoft Excel formula. The
Microsoft Excel formula was chosen because it is one of the
top stable software available. Randomly, 449 mice were tested,
showing that the Labinsane mobile app matched all (100%) the
individual anesthetic doses calculated by the Microsoft Excel
formula (Table 4) with no statistical difference (p = 0.9). These
results suggested no errors in the Labinsane mobile app code.
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TABLE 3 | Poisson regression.
Dependent variable Independent variables Prevalence ratioa 95% CI p-value
Lower Upper
Deatha App used (ref = no) 0.06 0.02 0.13 <0.0001
Strain (ref = Swiss) 2.13 0.39 11.55 0.3797
Age, weeks (ref = 7) 2.03 0.31 13.18 0.4585
Procedure (ref = wound) 0.54 0.11 2.61 0.4436
aThe probability of presenting the result “yes” was estimated; n = 939.
TABLE 4 | Labinsane validation.
Excel formula Labinsane
Animals 449 449
Minimum (µl) 114.6 114.6
Median (µl) 130.7 130.7
Maximum (µl) 249.8 250
Mean (µl) 146.1 145.9
Standard deviation (µl) 31.9 31.6
Standard error of the mean (µl) 1.5 1.5
Lower 95% confidence interval (CI; µl) 143 143
Upper 95% CI (µl) 149 148.8
Number of animals: n, 449. Median, mean, standard deviation, standard error, and
confidence interval comparing the Microsoft Excel spreadsheet and Labinsane mobile
app. Unpaired t-test: p-value, 0.9432.
DISCUSSION
The Principles of Humane Experimental Technique published in
1959 by Russell and Burch proposed that all efforts should be
made to minimize the use and suffering of experimental animals
in biological and health research (3R). Today, after 60 years, we
are still struggling to achieve the high standards idealized by
Russell and Burch.
Despite the recommended anesthetic doses being well known
worldwide, the final injected doses could be different than
those calculated. Several animals for experiments, preparation
of master anesthetic solutions, small drug volumes, and the
volumetric limitations of syringe systems could interfere in the
proper application of the recommended dose rates. We asked
whether we could improve the reported average mortality using
a ketamine and xylazine combination. First, it was tested in a
Microsoft Excel spreadsheet containing the proper prescription
formula. However, after implementation, adherence to the new
MS Excel-based dose calculation brought new difficulties for
operators—for instance, animal biosafety limitations, aseptic
concerns about personal computers in laboratories performing
animal procedures, low volumes of anesthetic to remove from
the flask, highly concentrated residual anesthetic volumes in the
syringe, and limitations of syringe systems without the capacity
to fractionate small volumes of anesthetics. To solve some of
these complexities, we tried a different approach and developed a
mobile app. Using the Labinsane mobile app on personal mobile
phones, researchers, and operators were able to use personal
devices in the workplace. Mobile phones were easily disinfected
and speeded up master anesthetic calculations as well as the
individual anesthetic dose calculation.
Several advantages of volatile anesthetics over injectables
have been shown. However, anesthetic procedures using airways
require specific equipment, which can interfere with the
experiment result and increases both cost and workspace usage.
If volatile anesthetics cannot be applied, injectable anesthesia
is indicated (18). Intraperitoneal anesthetic protocols based on
the injection of ketamine–xylazine solution are widely used
in experiments with rodents due to the low cost, minimum
training, and the fact that no equipment is being required (4).
Nevertheless, there is a wide variation in the recommended
dose, which is possibly due to differences between mouse
strains, type, and duration of the procedure, health conditions,
age, and research goals (4, 8, 10, 19). Previous reports
compared the efficacy of the intraperitoneal and subcutaneous
administration of ketamine (100mg/ml) and xylazine (20mg/ml)
solution for inducing surgical anesthesia. Among C57BL/6,
BALB, and ICR mice, no death occurred in the subcutaneous
administration groups, while 16.7% (10 of 60 mice) of mice
injected intraperitoneally died (10). Specifically, more females
died after the intraperitoneal injection compared withmales (10).
Previous reports have also shown that the ketamine, xylazine,
and diazepam combination is effective to induce anesthesia for
surgical procedures (20–24).
The principal causes of unsafe medication in humans are
related to failures in drug preparation and lack of treatment
standardization (25). Experimental animal safety should also
ensure the proper anesthetic dose calculation and administration.
In this way, the Labinsane mobile app seeks to ensure the
safety of C57BL/6 and Swiss mice by pursuing proper individual
anesthetic dose calculation and administration.
We decided to use “4” and “3” as dilution factors in the
mobile app formulas, with the aim to increase the total volume
to administer. By increasing the dilution factor, we decreased
the anesthetic agent concentrations in every microliter of the
final cocktail. In this way, if any operator mistake occurs, the
volume of the anesthetic agents is low (in µl), protecting the
mice from overdoses. These dilution factors helped the operators
with anesthetic volumes that were easier to fit in common insulin
syringes (1ml). This altogether protects the mice from human
mistakes. This approach suggests that the mobile app could
improve mice safety related to anesthetic administration. We
believe that this method could be better than just calculating the
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drug dosages on a milligram-per-kilogram basis with standard
protocol because it is ready to use, already tested, and could be an
open initiative to automate the drug calculation process in other
species and strains.
TheMITApp Inventor platform (appinventor.mit.edu) allows
researchers to easily create new mobile apps. Indeed App
Inventor apps have been shown to improve data analysis and
help in making well-informed decisions (12). The use of the App
Inventor has also contributed to children’s learning (26), home
automation (27), and self-care actions (28). Our study established
that Labinsane, a MIT-based mobile app, helps researchers to
markedly reduce anesthesia-related mortality. We encourage
researchers to validate new experimental animal strains and
species based on modular collaboration with Labinsane to
decrease anesthetic-related death.
Due to the retrospective nature of this study, we recommend
limiting the interpretation of our results to the variants
herein described as well as avoiding extrapolation to other
scenarios. The mice in the mobile app protocol received a lower
ketamine/xylazine drug concentration compared to the standard
protocol. We also collected records only from male mice, and
previous reports (10) showed that female mice mortality is
higher than male mortality. In this way, future studies will
be needed to determine the mobile app accuracy for female
anesthesia induction.
The xylazine and ketamine dose regime proposed by the
mobile app protocol is lower than the standard dose used, and
even the ratio between the dose of xylazine and ketamine between
groups is different. In fact, the mobile app protocol proposes
a reduction, especially of the xylazine dose. Similar to previous
studies, the mobile app protocol introduced a different dose
regimen in accordance with the duration of the procedure (4,
8, 10, 19). The xylazine dosage used in the standard protocol
was also 0.6 mg/kg higher than the higher dose reported in
the literature. In this way, future studies will be necessary to
determine the relationship of anesthesia-related mortality with
a similar ketamine/xylazine concentration using this mobile
app initiative.
CONCLUSIONS
The current study was conducted to validate a mobile app for
anesthetic dose calculation. The results of the study demonstrated
that a MIT App Inventor-based app decreased anesthesia-
related mortality and matched all anesthetic dose calculations.
The results suggest that anesthesia-related mortality can be
minimized even more using information technology approaches.
The open code of Labinsane will be available after publication
on the GitHub site (https://github.com/blinkeado/labinsane) for
future protocol validation.
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